(Your digital wall Editorial):- Seattle, May 30, 2019 (Issuewire.com) – Global Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in 2017, and is projected to exhibit a CAGR of 5.8% over the forecast period (2019 – 2026), as highlighted in a new report published by Coherent Market Insights.
Major players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbottLaboratories, Bayer AG, and Zydus Pharmaceuticals.
More on your digital wall:
- Maria Castello-Ramirez, MD, a Vascular Surgeon with Penn State Heart and Vascular Institute IO Silver Clinic
- Diane F. Lam, MD, an Anesthesiologist and Pain Management Specialist with NYU Langone Health
- North Springs Resources Corp.(OTCMKTS: NSRS)- Corporate Update; Announcement
- Is Adele Suffering From An Eating Disorder As She Shocks Everyone With Her Shocking Weight Loss?
- Red Dead Redemption 2 Can be Reviewed by PC Gamers Only on One Platform but with Many User Drawbacks
Get Access to PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2665
The infertility drugs market size is expanding, owing to increasing research studies for the development of breakthrough drugs for the treatment of infertility. According to research conducted at Princeton University in 2018, researchers have identified a key protein in old, poor-quality Caenorhabditis elegans (microscopic worm) eggs, which controls the aging of gametes. Researchers successfully blocked this protein during the fertile period of the worm (equivalent to woman’s fertility in the thirties) and extended egg viability beyond the normal span. If this protein could be removed from human genes, that could represent a 3 to a 6-year extension of female fertility.
Increasing awareness about reproductive health in the population is also highly contributing to the infertility drugs market growth. For instance, RESOLVE – The National Infertility Association organizes National Infertility Awareness Week (NIAW) every year in the last week of April since 2010. The goal of the week is to raise awareness about infertility in the maximum population, to encourage advocacy for insurance in infertility drugs, and help couples with infertility cope with their disease.
Browse 17 Market Data Tables and 12 Figures spread through 145 Pages and in-depth TOC on ” Global Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026″
Request Customization Of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2665
Key Takeaways of the Infertility Drugs Market:
The global infertility drugs market is expected to expand at a CAGR of 5.8% during the forecast period (2019-2026), owing to increasing research & development and new infertility drug launches by companies.
Among the drug type, the Clomiphene citrate segment is expected to hold a major revenue share in 2026, as it is the most effective drug to treat infertility. According to a study published in National Centre for Biotechnology Information (NCBI) in 2012, a comparative study on effectiveness of clomiphene citrate and tamoxifen in ovulation induction in infertile women showed that women treated with Clomiphene citrate showed a 64% increase in pregnancy rate than the women treated with tamoxifen, which showed only a 40% increase in pregnancy rate.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Coherent Market Insights
This Press Release was originally published by IssueWire. Read the original article here.
More on your digital wall:
- Sun Point Wellness Counseling Center in Lancaster is Growing Their Team of Compassionate Therapists
- Intranet powered by MS OneNote
- Greg Efros, DMD, MS, an Orthodontist with Efros Orthodontics
- Sebastian R. Eid, MD, FACS, a Surgeon with Advanced Laparoscopic Associates
- Nawar Alnoman, DDS, MS, Dentist with Dental Logic / 1st Family Dental